Cargando…

Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19

Detalles Bibliográficos
Autores principales:	Keshmiri Neghab, Hoda, Azadeh, Seyedeh Sara, Soheilifar, Mohammad Hasan, Dashtestani, Fariba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Avicenna Research Institute 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502165/ https://www.ncbi.nlm.nih.gov/pubmed/33014319

Ejemplares similares

Light Up the COVID-19
por: Neghab, Hoda Keshmiri, et al.
Publicado: (2022)

Ultrasound and Sonogenetics: A New Perspective for Controlling Cells with Sound
por: Azadeh, Seyedeh Sara, et al.
Publicado: (2021)

Cellular Therapy: The Hope for Covid-19
por: Nobari, Sima, et al.
Publicado: (2022)

Network Analysis of Common Genes and Transcriptional Factors between Celiac Disease and Inflammatory Bowel Diseases
por: Izadi, Fereshteh, et al.
Publicado: (2020)

Angioregulatory microRNAs in Colorectal Cancer
por: Soheilifar, Mohammad Hasan, et al.
Publicado: (2019)

Wound dressings incorporating microRNAs: Innovative therapy for diabetic wound treatment
por: Soheilifar, Mohammad Hasan, et al.
Publicado: (2022)

miR-1290 contributes to oncogenesis and angiogenesis via targeting of THBS1, DKK3 and, SCAI
por: Soheilifar, Mohammad Hasan, et al.
Publicado: (2022)

Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies
por: Soheilifar, Mohammad Hasan, et al.
Publicado: (2021)

The Potential Anti-Inflammatory Effects of Zerumbone in COVID-19 Patients
por: Dehghan, Razieh, et al.
Publicado: (2021)

Co-regulatory Network of Transcription Factors and miRNAs in Colorectal Cancer Pathogenesis
por: Soheilifar, Mohammad Hasan, et al.
Publicado: (2020)

Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations
por: Gaibani, Paolo, et al.
Publicado: (2021)

Covid-19: Lessons from hospital preparedness for radiation accidents
por: Keshmiri, Saeid, et al.
Publicado: (2020)

Is photodynamic therapy a viable antiviral weapon against COVID-19 in dentistry?
por: Joseph, Betsy, et al.
Publicado: (2021)

Drug-drug interaction with oral antivirals for the early treatment of COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2023)

Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2022)

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
por: Molina, J.M., et al.
Publicado: (2020)

Drug-drug interaction with oral antivirals for early treatment of COVID-19 – Authors’ reply
por: Larsen, Carsten Schade
Publicado: (2023)

COVID-19 antiviral therapy for non-hospitalized immunosuppressed patients with rheumatic diseases is feasible with positive outcomes
por: Lin, Chung M A, et al.
Publicado: (2022)

Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
por: Moradi, Seyed Zachariah, et al.
Publicado: (2020)

Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy
por: Chen, Fangmin, et al.
Publicado: (2021)

Antiviral therapy in acute viral hepatitis B: why and when
por: Morelli, Giuseppe, et al.
Publicado: (2009)

The Most Important Species of Nosocomial Infection and the Most Important Wards Susceptible to Nosocomial Infection
por: FARZIANPOUR, Fereshteh, et al.
Publicado: (2014)

The Effectiveness of Antiviral Treatment in Severe COVID-19 Patients in Wuhan, China: A Multicenter Study
por: ZHOU, Xian Long, et al.
Publicado: (2022)

Recent Advances and Impact of Chemotherapeutic and Antiangiogenic Nanoformulations for Combination Cancer Therapy
por: Rajora, Amit Kumar, et al.
Publicado: (2020)

Potential of nanoformulations in malaria treatment
por: Chaves, Janaina Braga, et al.
Publicado: (2022)

Willing to Pay for Antiviral Treatment of Hepatitis B Patients
por: ZHANG, Hua, et al.
Publicado: (2016)

Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible?
por: Shukla, Dr. Ajay Kumar, et al.
Publicado: (2021)

Hydroxyurea: A useful adjunct to the standard antiviral therapy in chronic hepatitis B
por: Alavi-Moghaddam, Mostafa
Publicado: (2011)

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain
por: Lens, Sabela, et al.
Publicado: (2020)

Exosome-Coated tPA/Catalase Nanoformulation for Thrombolytic Therapy
por: Khalil, Sara, et al.
Publicado: (2023)

The Treatment of Acquired Hemophilia with Combination Therapy of Immunosuppressives and Immunoadsorption
por: Uğur Bilgin, Aynur, et al.
Publicado: (2014)

Potential of heparin and nafamostat combination therapy for COVID‐19
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective
por: Davatgaran-Taghipour, Yasamin, et al.
Publicado: (2017)

Delayed antiviral medical treatment increased PTSD development among COVID-19 hospitalized patients: Greater impact in males
por: Liu, Nianqi, et al.
Publicado: (2022)

Repurposing Hepatitis C Direct-Acting Antivirals Against COVID-19
por: Kumar, Pramod, et al.
Publicado: (2021)

Antiviral effect of amiodarone and its possible role in COVID-19: An appraisal
por: Lonare, Snehal, et al.
Publicado: (2020)

Curcumin Nanoformulation for Cervical Cancer Treatment
por: Zaman, Mohd S., et al.
Publicado: (2016)

Pathology and Treatment of Psoriasis Using Nanoformulations
por: Thirumal, Divya, et al.
Publicado: (2023)

Combination of Statins and NSAIDs as a Potential Novel Addition to the Limited Anti-Breast Cancer Weaponry: A True Synergistic Model
por: Talaiezadeh, Abdolhassan, et al.
Publicado: (2019)

A simple recommendation to prevent COVID-19 spread by patients with tracheostomy tube
por: Shadmehr, Mohammad Behgam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rj8lfmh7s1vak4olv8vvpk7k25